Search Results - "Halvatsiotis, P"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Changes in N-terminal pro b-type natriuretic peptide according to SGLT2 inhibitor utilization patterns in patients hospitalized for decompensated heart failure: a prospective cohort study by Fountoulakis, P, Theofilis, P, Sagris, M, Oikonomou, E, Siasos, G, Halvatsiotis, P, Tsioufis, P, Aggeli, C, Tsioufis, K, Tousoulis, D

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction Sodium-glucose cotransporter-2 (SGLT2) inhibitors have found success in treating patients with chronic heart failure (HF) across the…”
    Get full text
    Journal Article
  3. 3

    Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients by Raptis, A E, Tountas, N B, Yalouris, A G, Halvatsiotis, P G, Raptis, S A

    Published in Hormone and metabolic research (01-02-1996)
    “…The combination of a sulfonylurea with a biguanide improves the pancreatic beta-cell insulin secretion and the insulin utilization in peripheral tissues in…”
    Get more information
    Journal Article
  4. 4

    Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment by SREEKUMAR, Raghavakaimal, HALVATSIOTIS, Panagiotis, COENEN SCHIMKE, Jill, SREEKUMARAN NAIR, K

    Published in Diabetes (New York, N.Y.) (01-06-2002)
    “…Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment Raghavakaimal Sreekumar , Panagiotis Halvatsiotis , Jill…”
    Get full text
    Journal Article
  5. 5

    Insulin effect on leucine kinetics in type 2 diabetes mellitus by Halvatsiotis, P G, Turk, D, Alzaid, A, Dinneen, S, Rizza, R A, Nair, K S

    Published in Diabetes, nutrition & metabolism (01-06-2002)
    “…Insulin-induced glucose disposal is impaired in Type 2 diabetes mellitus (T2DM). To determine whether insulin-induced suppression of protein breakdown also is…”
    Get more information
    Journal Article
  6. 6

    Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes by HALVATSIOTIS, Panagiotis, SHORT, Kevin R, BIGELOW, Maureen, SREEKUMARAN NAIR, K

    Published in Diabetes (New York, N.Y.) (01-08-2002)
    “…Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes Panagiotis Halvatsiotis , Kevin R. Short , Maureen Bigelow and…”
    Get full text
    Journal Article
  7. 7

    Identification of Amadori-Modified Plasma Proteins in Type 2 Diabetes and the Effect of Short-Term Intensive Insulin Treatment by Jaleel, Abdul, Halvatsiotis, Panagiotis, Williamson, Brian, Juhasz, Peter, Martin, Stephen, Nair, K. Sreekumaran

    Published in Diabetes care (01-03-2005)
    “…OBJECTIVE:--Growing evidence supports that nonenzymatic glycation products may cause hyperglycemia-induced diabetes complications. Amadori-modified proteins…”
    Get full text
    Journal Article
  8. 8

    Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus by Dimitriadis, G, Raptis, S, Raptis, A, Hatziagelaki, E, Mitrakou, A, Halvatsiotis, P, Ladas, S, Hillebrand, I

    Published in Klinische Wochenschrift (02-05-1986)
    “…BAYo1248 and BAYm1099 are two new alpha-glucosidase inhibitors. Postprandial glucose tolerance was significantly improved and postprandial insulin requirements…”
    Get full text
    Journal Article
  9. 9

    The effects of the somatostatin analogue SMS 201-995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas by Hadjidakis, D J, Halvatsiotis, P G, Ioannou, Y J, Mavrokefalos, P J, Raptis, S A

    Published in Diabetes research and clinical practice (13-07-1988)
    “…On the basis of the inhibitory actions of the somatostatin analogue SMS 201-995 on growth hormone (GH) and glucagon (IRG) secretion we investigated its effects…”
    Get more information
    Journal Article